XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.25.3

Financial Instruments | 9 Months Ended
--- | ---
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract] |
Financial Instruments | Financial Instruments The following is a summary of available-for-sale marketable securities, as of September 30, 2025 and December 31, 2024, respectively (in thousands):
| September 30, 2025
| Amortized Cost |  | Unrealized Gains |  | Unrealized Losses |  | Fair Value
Marketable securities: |  |  |  |  |  |  |
Corporate securities (1) | $ | 47,459 |  |  | $ | 130 |  |  | $ | (3) |  |  | $ | 47,586 |
U.S. agency securities | 3,090 |  |  | — |  |  | — |  |  | 3,090 |
Total Marketable securities | $ | 50,549 |  |  | $ | 130 |  |  | $ | (3) |  |  | $ | 50,676 |
(1)Comprised primarily of corporate bonds |  |  |  |  |  |
| December 31, 2024
| Amortized Cost |  | Unrealized Gains |  | Unrealized Losses |  | Fair Value
Marketable securities: |  |  |  |  |  |  |
Corporate securities (1) | $ | 43,008 |  |  | $ | 9 |  |  | $ | (74) |  |  | $ | 42,943 |
U.S. agency securities | 3,097 |  |  | — |  |  | (4) |  |  | 3,093 |
Total Marketable securities | $ | 46,105 |  |  | $ | 9 |  |  | $ | (78) |  |  | $ | 46,036 |
(1)Comprised primarily of corporate bonds |  |  |  |
As of September 30, 2025, the fair values of available-for-sale marketable securities, by remaining contractual maturity, were as follows (in thousands):
Due within one year | $ | 33,903 |
Due in one to five years | 16,773 |
Total | $ | 50,676 |
The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. Fair values were determined for each individual security in the investment portfolio. The Company does not believe that any unrealized losses are attributable to credit-related factors based on its evaluation of available evidence. To determine whether a decline in value is related to credit loss, the Company evaluates, among other factors: the extent to which the fair value is less than the amortized cost basis, changes to the rating of the security by a rating agency and any adverse conditions specifically related to an issuer of a security or its industry. The Company does not intend to sell the instruments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be maturity. Unrealized gains and losses on marketable securities are presented net of tax.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration